According to Market Research Future (MRFR), the global post-traumatic stress disorder (PTSD) market is predicted reach USD 7.3 billion, while expanding at a CAGR of 4.8% by 2025. Rising sexual assault cases is anticipated to be one of the most significant factors driving post-traumatic stress disorder market 2020. Furthermore, the increasing cross-border tension and violence has resulted in surged incidence of PTSD among soldiers returning from war, which is likely to stimulate the market during the evaluation period.In addition, the growing number of therapies for PTSD treatment is projected to favor the market growth. The growing research regarding the usage of cannabidiol (CBD) is anticipated to stimulate the PTSD demand and strengthen the market. Apart from these factors, the increasing number of clinical trials is likely to positively influence the PTSD market in the forecast period.However, side effects of some drugs used are projected to hinder the market growth during the evaluation period. On the contrary, growing anxiety issues along with aforementioned causes are likely to underpin the PTSD market. also read @ https://www.marketwatch.com/press-release/post-traumatic-stress-disorder-market-size-is-anticipated-to-reach-usd-73-billion-by-2025-2020-11-24
Post-Traumatic Stress Disorder Market SegmentationThe segment analysis of the global post-traumatic stress disorder market is done by end-user and treatment.The end-user-based segments of the global post-traumatic stress disorder market are ambulatory surgical centers and hospitals and clinics. Among these, hospitals and clinic segment is projected to be the largest segment during the forecast period.The treatment-based segments of the global post-traumatic stress disorder market are medication and psychotherapy. As per the analysis, the medication segment is projected to be the largest segment during the forecast period.Post-Traumatic Stress Disorder Market Regional AnalysisBased on the region, the global post-traumatic stress disorder market is segmented into the Americas, Asia-Pacific, Europe, and the Middle East & Africa. According to the analysis by MRFR, the global post-traumatic stress disorder market is anticipated to be dominated by the Americas. The Americas is estimated to be the largest post-traumatic stress disorder market owing to the rising cases of PTSD in the region. Besides, the growing per capita healthcare expenditure is predicted to be another potent factor developing the regional market during the forecast period. The US and Canada are likely to play a significant role during the review period. Further, the growing incidence of anxiety in the region is projected to develop the market in the coming period.Europe is projected to be a lucrative post-traumatic stress disorder market during the forecast period. The regional market growth can be attributed to the growing sexual violence and the growing research and development programs. Furthermore, the presence of established pharmaceuticals players is anticipated to grow the regional market in the coming period. The APAC region is expected to be the fastest growing market during the forecast period. The growing border tension and the increasing rape cases in the region are likely to be the most significant factor augmenting the regional market.Besides, the surged road accidents are expected to develop the market during the evaluation period. The MEA region is likely to acquire the least market share during the evaluation period. However, the region is likely to grow in the coming period during owing to the increasing initiatives taken by the government. Further, the growing investment in the healthcare sector is anticipated to drive the market in the coming period.Post-Traumatic Stress Disorder Market Key PlayersSome of the renowned players of the global post-traumatic stress disorder market are Marinus Pharmaceuticals, Inc. (US), Azevan Pharmaceuticals (US), Bionomics (Australia), GlaxoSmithKline (UK), Greenstone LLC (US), Pfizer (US), H. Lundbeck A/S (Denmark), Eli Lilly and Company (US), Tonix Pharmaceuticals Holding Corp. (US), and Mylan NV (US).Browse Detailed TOC with COVID-19 Impact Analysis at:https://www.marketresearchfuture.com/reports/post-traumatic-stress-disorder-market-8376 About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.Contact:Akash AnandMarket Research Future+1 646 845 9312Email: sales@marketresearchfuture.com